Bull Run

Advanced stock screening and portfolio analysis for Indian equity markets.

Navigation

Tools & Features

  • Premium Features
© 2025 Bull Run. All rights reserved.
info@bullrun.co.in

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities. Bull Run is not a SEBI-registered Research Analyst/Investment Adviser.

HomeStocksPackaged FoodsSampre Nutritions Ltd

Sampre Nutritions Ltd Stock Price Today (NSE: SAMPRE)

Sampre Nutritions Ltd

SAMPREPackaged Foods
₹18.88+₹0.00 (+0.00%)↑
As on 18 Feb 2026, 09:18 am ISTMarket Closed

Fundamental Score

...

Sampre Nutritions Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis

Sampre Nutritions Ltd share price today is ₹18.88, up +0.00% on NSE/BSE as of 18 February 2026. Sampre Nutritions Ltd (SAMPRE) is a Small-cap company in the Packaged Foods sector with a market capitalisation of ₹268.19 (Cr). The 52-week high for SAMPRE share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of -12.70% and a debt-to-equity ratio of 0.17.

Sampre Nutritions Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
+0.00%

Returns & Performance

Poor

ROE

-12.70%
Poor

ROCE

-7.13%
Poor

OPM (5Y)

8.92%

Div Yield

0.00%

Sampre Nutritions Ltd Valuation Check

P/E Ratio

N/A
Poor

Industry P/E

48.72x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

268.19 (Cr)

Growth Engine

Excellent

Profit Growth (Q)

641.67%
Excellent

Sales Growth (Q)

37.55%
Poor

Sales Growth (5Y)

0.22%

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Balance Sheet Health

Excellent

Debt to Equity

0.17x
Poor

Int. Coverage

-2.76x

Free Cash Flow (5Y)

-2.75 (Cr)

Shareholding

Good

Promoter

15.45%
Poor

FII

0.00%
Poor

DII

0.00%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

Sampre Nutritions Share Price: A Value Investor's Perspective

The packaged foods industry, while generally recession-resistant, demands careful stock selection. Brands perceived as "value" can quickly be replaced by newer, cheaper alternatives, eroding market share and profitability. This analysis examines the Sampre Nutritions share price (₹24.32) through the lens of a conservative value investor prioritizing capital preservation. This assessment is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, focusing on key metrics that indicate long-term viability.

One immediate concern arises from the company's profitability. Sampre Nutritions currently reports a negative Return on Capital Employed (ROCE) of -7.13%. ROCE measures how efficiently a company generates profits from its capital. A negative ROCE suggests that the company is destroying value, not creating it. This directly impacts the strength of any potential economic "moat." Without adequate returns, reinvestment becomes challenging, and the ability to defend market share against competitors weakens.

The absence of a Price-to-Earnings (PE) ratio further complicates the analysis. A PE ratio provides a basic benchmark for comparing a company's valuation to its earnings. The lack of a positive PE suggests the company isn't currently profitable or has inconsistent earnings. This lack of profitability raises significant red flags for a value investor seeking consistent returns and capital appreciation.

Comparing Sampre Nutritions Ltd. to its peers, such as Bikaji Foods International Ltd, highlights potential differences in management quality and execution. While both companies operate in the packaged foods sector, Bikaji has demonstrated a stronger ability to generate positive returns and navigate the competitive landscape. Management effectiveness in capital allocation, brand building, and operational efficiency are critical drivers of long-term shareholder value and are reflected in Bikaji's stock performance and financials. The difference in performance may imply varying levels of competence in areas like supply chain management, marketing strategies, and product innovation which directly influence the bottom line.

In conclusion, a negative ROCE and the absence of a positive PE ratio suggest significant challenges for Sampre Nutritions. Further investigation into the root causes of these issues, and a comparison of management strategies against more successful peers, are crucial for determining the long-term viability of the company and the potential for future value creation. This remains an observational analysis based on publicly available data.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Sampre Nutritions Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of SAMPRE across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Robust Profit Growth (641.67%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (37.55%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Conservative Debt Levels (D/E: 0.17)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

7 factors identified

Below-Average Return on Equity (-12.70%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (-7.13%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Limited Growth History (0.22% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.

Weak Interest Coverage (-2.76x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-2.75 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (15.45%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Sampre Nutritions Ltd Financial Statements

Comprehensive financial data for Sampre Nutritions Ltd including income statement, balance sheet and cash flow

About SAMPRE (Sampre Nutritions Ltd)

Sampre Nutritions Ltd (SAMPRE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Packaged Foods sector with a current market capitalisation of ₹268.19 (Cr). Sampre Nutritions Ltd has delivered a Return on Equity (ROE) of -12.70% and a ROCE of -7.13%. The debt-to-equity ratio stands at 0.17, reflecting the company's capital structure. Investors tracking SAMPRE share price can monitor key metrics including P/E ratio, promoter holding of 15.45%, and quarterly earnings growth.

Company Details

Symbol:SAMPRE
Industry:Packaged Foods
Sector:Packaged Foods
Website:https://www.sampreltd.com

Key Leadership

Mr. Brahma Kishanchand Gurbani
Chairman & MD
Mr. Vishal Ratan Gurbani
VP & Whole-Time Director
Mr. Vamshi Srinivas Vempati
Chief Financial Officer

Latest News

Multibagger smallcap stock reaches ex-date for 1:2 stock split, 1:1 bonus issue. What it means for investo - The Economic Times
The Economic Times• 11/13/2025
Sampre Nutritions Inks INR 30 Crore Deal with Tolaram Wellness for Nutraceutical Production - scanx.trade
scanx.trade• 8/28/2025
Teachers' Day 2025: Inspiring speech ideas and sample speech in English for school programmes - Times of India
Times of India• 9/5/2025

SAMPRE Share Price: Frequently Asked Questions

What is the current share price of Sampre Nutritions Ltd (SAMPRE)?

As of 18 Feb 2026, 09:18 am IST, Sampre Nutritions Ltd share price is ₹18.88. The SAMPRE stock has a market capitalisation of ₹268.19 (Cr) on NSE/BSE.

Is SAMPRE share price Overvalued or Undervalued?

SAMPRE share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 48.72x. Based on this relative valuation, the Sampre Nutritions Ltd stock appears to be Fairly Valued against its sector peers.

What is the 52-week high and low of SAMPRE share price?

The 52-week high of SAMPRE share price is ₹N/A and the 52-week low is ₹N/A.

What factors affect the Sampre Nutritions Ltd share price?

Key factors influencing SAMPRE share price include quarterly earnings growth (Sales Growth: 37.55%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Sampre Nutritions Ltd a good stock for long-term investment?

Sampre Nutritions Ltd shows a 5-year Profit Growth of N/A% and an ROE of -12.70%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.17 before investing in SAMPRE shares.

How does Sampre Nutritions Ltd compare with its industry peers?

Sampre Nutritions Ltd competes with major peers in the Packaged Foods. Investors should compare SAMPRE share price P/E of 0.00x and ROE of -12.70% against the industry averages to determine competitive standing.

What is the P/E ratio of SAMPRE and what does it mean?

SAMPRE share price has a P/E ratio of N/Ax compared to the industry average of 48.72x. Investors pay ₹N/A for every ₹1 of annual earnings.

How is SAMPRE performing according to Bull Run's analysis?

SAMPRE has a Bull Run fundamental score of 19.9/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does SAMPRE belong to?

SAMPRE operates in the Packaged Foods industry. This classification helps understand the competitive landscape and sector-specific trends affecting Sampre Nutritions Ltd share price.

What is Return on Equity (ROE) and why is it important for SAMPRE?

SAMPRE has an ROE of -12.70%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Sampre Nutritions Ltd generates profits from shareholders capital.

How is SAMPRE debt-to-equity ratio and what does it indicate?

SAMPRE has a debt-to-equity ratio of 0.17, which indicates conservative financing with low financial risk.

What is SAMPRE dividend yield and is it a good dividend stock?

SAMPRE offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Sampre Nutritions Ltd shares.

How has SAMPRE share price grown over the past 5 years?

SAMPRE has achieved 5-year growth rates of: Sales Growth 0.22%, Profit Growth N/A%, and EPS Growth N/A%.

What is the promoter holding in SAMPRE and why does it matter?

Promoters hold 15.45% of SAMPRE shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Sampre Nutritions Ltd.

What is SAMPRE market capitalisation category?

SAMPRE has a market capitalisation of ₹268 crores, placing it in the Small-cap category.

How volatile is SAMPRE stock?

SAMPRE has a beta of N/A. A beta > 1 suggests the Sampre Nutritions Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is SAMPRE operating profit margin trend?

SAMPRE has a 5-year average Operating Profit Margin (OPM) of 8.92%, indicating the company's operational efficiency.

How is SAMPRE quarterly performance?

Recent quarterly performance shows Sampre Nutritions Ltd YoY Sales Growth of 37.55% and YoY Profit Growth of 641.67%.

What is the institutional holding pattern in SAMPRE?

SAMPRE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Sampre Nutritions Ltd stock.

HomeScreenerBattleWatchlist